AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 82 filers reported holding AGILE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,000 | -27.8% | 25,000 | 0.0% | 0.01% | -41.7% |
| Q4 2020 | $72,000 | -5.3% | 25,000 | 0.0% | 0.02% | +41.2% |
| Q3 2020 | $76,000 | +8.6% | 25,000 | 0.0% | 0.02% | +6.2% |
| Q2 2020 | $70,000 | +48.9% | 25,000 | 0.0% | 0.02% | +77.8% |
| Q1 2020 | $47,000 | -68.7% | 25,000 | -58.3% | 0.01% | -18.2% |
| Q4 2019 | $150,000 | +26.1% | 60,000 | -40.0% | 0.01% | +57.1% |
| Q3 2019 | $119,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 31,839,850 | $42,348,000 | 0.28% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $978,000 | 0.14% |
| INVESTOR AB | 3,510,189 | $4,669,000 | 0.14% |
| Tibra Equities Europe Ltd | 241,100 | $321,000 | 0.10% |
| FIRST MIDWEST BANK TRUST DIVISION | 349,158 | $464,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 372,543 | $495,000 | 0.06% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 110,000 | $146,000 | 0.04% |
| Kalos Management, Inc. | 19,250 | $24,000 | 0.01% |
| Summit Global Investments | 110,100 | $146,000 | 0.01% |
| Founders Capital Management | 10,000 | $13,000 | 0.01% |